Cannabis News

January was a wild ride for cannabis news. From bureaucratic delays to groundbreaking research, here are three big updates you should know.

The DEA’s Cannabis Hearing? Yeah, It’s Delayed.

So, the DEA was supposed to hold a hearing on January 21 to discuss rescheduling cannabis from Schedule I to Schedule III (aka, moving it out of the “as bad as heroin” category). But surprise! It got postponed because of an appeal from someone involved. Now, everyone’s left wondering when or if the government will finally make a move. Classic.

Cannabis for Dementia? Science Says, “Let’s Find Out.”

Over at the University of Kentucky, researchers kicked off a study on cannabis for late-stage dementia patients. The goal? See if it helps with agitation and discomfort—two big struggles for those with advanced dementia. The study, called the LiBBY Study, is backed by the National Institutes of Health and FDA-approved. If it works, cannabis could become a legit option for easing symptoms. Finally, science catching up with common sense.

The Feds Want a “Game Plan” for Cannabis Research

The National Institute on Drug Abuse (NIDA) just dropped a new cannabis research roadmap, and it’s all about closing knowledge gaps. They want to figure out both the benefits and the risks (because, you know, balanced science and all that). This plan could shape future policies, regulations, and maybe even finally bring some clarity to the whole “is it medicine or not?” debate.

We at Great Northern hope you had a wonderful holiday season! Now that January is upon us, let’s reflect on some cannabis news highlights from December 2024 as we head into the new year.

DEA Initiates Hearings on Cannabis Rescheduling

In December, the DEA officially began hearings to consider reclassifying cannabis. Specifically, they are looking at moving it from Schedule I to Schedule III under the Controlled Substances Act. If this happens, it could reduce federal restrictions and make cannabis research easier. However, while advocates are excited about this step forward, critics are more cautious and wonder how much will really change. Overall, many are watching closely to see how this decision could shape the future of cannabis laws in the U.S.

Source: DEA to Hold Hearing on the Rescheduling of Marijuana

U.S. Appeals Court Reviews Federal Marijuana Ban

On December 5, a U.S. appeals court took a closer look at the federal marijuana ban. Businesses in Massachusetts argued that the ban no longer makes sense, especially since so many states have legalized cannabis. Yet, the judges appeared hesitant to challenge the current law. As a result, the long-standing conflict between state and federal cannabis laws remains unresolved. For now, it’s clear that this debate will continue to affect the cannabis industry across the country.

Source: US Appeals Court Skeptical of Challenge to Federal Marijuana Ban

New York Cannabis Advocates Urge Leadership Changes

In New York, cannabis advocates are calling for major changes in the state’s cannabis office. Specifically, they want new leaders with more experience in the industry. Many people are frustrated by delays and unfulfilled promises, especially in equity programs designed to help those harmed by past marijuana laws. Advocates believe that bringing in fresh leadership could fix these problems. In the end, they hope these changes will get the state’s cannabis program back on track and moving in the right direction.

Source: Pot advocates spar with Gov. Hochul over leadership and ‘knee-jerk changes’ with state cannabis office: ‘Failed commitments to equity’

What do you think of these news highlights? Let us know in the comments! Until next time, stay hazy!